Effect of beta-adrenergic blockade on plasma lactate concentration during exercise at high altitude.
When unacclimatized lowlanders exercise at high altitude, blood lactate concentration rises higher than at sea level, but lactate accumulation is attenuated after acclimatization. These responses could result from the effects of acute and chronic hypoxia on beta-adrenergic stimulation. In this investigation, the effects of beta-adrenergic blockade on blood lactate and other metabolites were studied in lowland residents during 30 min of steady-state exercise at sea level and on days 3, 8, and 20 of residence at 4300 m. Starting 3 days before ascent and through day 15 at high altitude, six men received propranolol (80 mg three times daily) and six received placebo. Plasma lactate accumulation was reduced in propranolol- but not placebo-treated subjects during exercise on day 3 at high altitude compared to sea-level exercise of the same percentage maximal oxygen uptake (VO2max). Plasma lactate accumulation exercise on day 20 at high altitude was reduced in both placebo- and propranolol-treated subjects compared to exercise of the same percentage VO2max performed at sea level. The blunted lactate accumulation during exercise on day 20 at high altitude was associated with reduced muscle glycogen utilization. Thus, increased plasma lactate accumulation in unacclimatized lowlanders exercising at high altitude appears to be due to increased beta-adrenergic stimulation. However, acclimatization-induced changes in muscle glycogen utilization and plasma lactate accumulation are not adaptations to chronically increased beta-adrenergic activity.
U.S. Army Research Institute of Environmental Medicine, Natick, MA 01760-5007.
A J
AJ
Young
P M
PM
Young
R E
RE
McCullough
L G
LG
Moore
A
A
Cymerman
J T
JT
Reeves
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000531:Altitude; D001786:Blood Glucose / Q000032:analysis; D002395:Catecholamines / Q000097:blood; D004311:Double-Blind Method; D015444:Exercise / Q000502:physiology*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006003:Glycogen / Q000032:analysis / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000097:blood; D007773:Lactates / Q000097:blood*; D008297:Male; D009132:Muscles / Q000737:chemistry / Q000378:metabolism / Q000648:ultrastructure; D010101:Oxygen Consumption / Q000502:physiology; D011433:Propranolol / Q000494:pharmacology; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007773:Lactates; D011943:Receptors, Adrenergic, beta; D006003:Glycogen; D011433:Propranolol